Insider Transactions in Q2 2024 at Pliant Therapeutics, Inc. (PLRX)

PLRX Quotes by TradingView

Insider Transaction List (Q2 2024)

Date Insider Transaction Ownership Type Shares Traded Value / Price
May 02 2024
Keith Lamont Cummings Chief Financial Officer
BUY
Exercise of conversion of derivative security
Direct
21,000 +7.17%
$42,000 $2.08 P/Share

Track Institutional and Insider Activities on PLRX

Follow PLIANT THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PLRX shares.

Notify only if

Insider Trading

Get notified when an Pliant Therapeutics, Inc. insider buys or sells PLRX shares.

Notify only if

News

Receive news related to PLIANT THERAPEUTICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PLRX